US FEDERAL HEALTH OFFICIALS SAYS ASTRAZENECA MAY HAVE USED OUTDATED DATA IN COVID-19 VACCINE TRIAL

Highlights

• In a statement issued on late Monday, the Data and Safety Monitoring Board said that it was concerned that the UK-based drugmaker may have provided an incomplete view of the efficacy data

• AstraZeneca had published the first data from an interim safety and efficacy analysis of more than 30,000 volunteers

According to a statement issued by the US federal health officials on Tuesday, results ....